Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(22)00129-3
PubMed Identifier: 35305699
Publication URI: http://europepmc.org/abstract/MED/35305699
Type: Journal Article/Review
Volume: 22
Parent Publication: The Lancet. Infectious diseases
Issue: 6
ISSN: 1473-3099